Rallybio annual r&d spending
2020
2021
2022
2023
2024
2025
Rallybio R&D Spending Growth & History (RLYB)
Rallybio's r&d spending was $19.6M for fiscal 2025.
View full Rallybio company overviewRallybio annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $19.6M | −$21.9M | −52.79% |
| 2024 | 2024-12-31 | $41.5M | −$12.0M | −22.48% |
| 2023 | 2023-12-31 | $53.5M | $12.9M | +31.59% |
| 2022 | 2022-12-31 | $40.7M | $13.8M | +51.21% |
| 2021 | 2021-12-31 | $26.9M | $9.3M | +52.63% |
| 2020 | 2020-12-31 | $17.6M | — | — |
Rallybio quarterly r&d spending
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $758,000 | −$5.3M | −87.52% |
| Q1 2026 | 2026-03-31 | $2.9M | −$2.9M | −49.85% |
| Q4 2025 | 2025-12-31 | $3.7M | −$3.7M | −50.51% |
| Q3 2025 | 2025-09-30 | $4.1M | −$4.1M | −49.72% |
| Q2 2025 | 2025-06-30 | $6.1M | −$6.9M | −53.08% |
| Q1 2025 | 2025-03-31 | $5.7M | −$7.2M | −55.74% |
| Q4 2024 | 2024-12-31 | $7.4M | −$8.5M | −53.62% |
| Q3 2024 | 2024-09-30 | $8.2M | −$5.0M | −37.99% |
| Q2 2024 | 2024-06-30 | $12.9M | −$184,000 | −1.40% |
| Q1 2024 | 2024-03-31 | $12.9M | $1.7M | +15.48% |
| Q4 2023 | 2023-12-31 | $15.9M | $5.1M | +47.54% |
| Q3 2023 | 2023-09-30 | $13.3M | $1.2M | +9.73% |
| Q2 2023 | 2023-06-30 | $13.1M | $3.0M | +29.51% |
| Q1 2023 | 2023-03-31 | $11.2M | $3.6M | +46.47% |
| Q4 2022 | 2022-12-31 | $10.8M | $4.7M | +77.11% |
| Q3 2022 | 2022-09-30 | $12.1M | $7.2M | +144.15% |
| Q2 2022 | 2022-06-30 | $10.1M | $3.3M | +48.69% |
| Q1 2022 | 2022-03-31 | $7.6M | −$1.4M | −15.37% |
| Q4 2021 | 2021-12-31 | $6.1M | — | — |
| Q3 2021 | 2021-09-30 | $5.0M | −$170,000 | −3.31% |
| Q2 2021 | 2021-06-30 | $6.8M | $3.7M | +120.50% |
| Q1 2021 | 2021-03-31 | $9.0M | — | — |
| Q3 2020 | 2020-09-30 | $5.1M | — | — |
| Q2 2020 | 2020-06-30 | $3.1M | — | — |
Rallybio r&d spending trends
Over the last five fiscal years, Rallybio's r&d spending increased from $17.6M to $19.6M, a change of $2.0M. The latest reported quarter, Q2 2026, shows $758,000.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rallybio source filings ↗